Filing Details

Accession Number:
0001181431-12-054537
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-10-11 19:56:16
Reporting Period:
2012-10-10
Filing Date:
2012-10-11
Accepted Time:
2012-10-11 19:56:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1505512 Regulus Therapeutics Inc. RGLS Pharmaceutical Preparations (2834) 264738379
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
874015 Isis Pharmaceuticals Inc 2855 Gazelle Court
Carlsbad CA 92010
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-10-10 6,299,500 $0.00 6,299,500 No 4 C Direct
Common Stock Acquisiton 2012-10-10 750,000 $4.00 7,049,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2012-10-10 6,299,500 $0.00 6,299,500 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
Footnotes
  1. Upon the closing of the Issuer's initial public offering, every 2 shares of Series A Preferred Stock automatically converted into 1 share of Common Stock and had no expiration date.
  2. The shares were purchased at the Issuer's initial public offering.